Assessment of over 2,800 patients highlights the profound impact of the BCI test in helping to predict the likelihood of extended endocrine therapy benefit for patients with HR+ breast cancer

To prepare for if the current H5N1 outbreak worsens, Hologic will work with the CDC to develop reagents that may be used for H5N1 testing

Study assesses prognostic value of BCI testing and its potential in supporting de-escalation of primary adjuvant endocrine therapy

Better testing for M. gen reduces rates of undiagnosed illness and AMR likelihood

The Genius™ Digital Diagnostics System for Cervical Cancer Screening Can Help More Accurately Detect Disease

How cytologists continue to meet the ever-increasing need for diagnostic screening

The potential of AI and digitization in transforming cytology in your lab

Pap and HPV testing together is highly sensitive and offers the most comprehensive defense against rising rates of cervical cancer